The Dow Chemical Company

U.S.A

CPhI India 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Dosage Form : Tablet

Grade :

Brand Name : WALOCEL™ C

Application : Coating Systems & Additives, Rheology Modifiers

Excipient Details : Tablet Coating, Rheology Modifier

Pharmacopoeia Ref :

Technical Specs :

Ingredient(s) : Carboxymethyl cellulose sodium

Dosage Form : Tablet

Grade :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Ingredient(s) : Carboxymethyl cellulose sodium

Dosage Form : Tablet

Category : Coating Systems & Additives, Rheology Modifiers

Brand : WALOCEL™ C

Applications : Tablet Coating, Rheology Modifier

Pharmacopoeia Ref : Not Available

Technical Specs : Not Available

Grade : Not Available

Looking for Pharmaceutical Excipients offered by The Dow Chemical Company? Find Beclomethasone Dipropionate Monohydrate to address your drug delivery challenges on PharmaCompass.

Beclomethasone Dipropionate Monohydrate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

51 API Suppliers

18 USDMF

12 CEP/COS

2 JDMF

5 EU WC

3 KDMF

12 NDC API

32 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

5 Drugs in Development

FINISHED DOSAGE FORMULATIONS

164 FDF Dossiers

14 FDA Orange Book

91 Europe

7 Canada

4 Australia

14 South Africa

34 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SPRAY, METERED;NASAL - EQ 0.042MG DIPROP/SPRAY

AEROSOL, METERED;NASAL - 0.04MG/ACTUATION

AEROSOL, METERED;NASAL - 0.08MG/ACTUATION

AEROSOL, METERED;INHALATION - 0.04MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

AEROSOL, METERED;INHALATION - 0.08MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

1 SPI Pharma

1 DKSH

1 Jai Radhe Sales

6 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

6 Actylis

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 BASF

2 DFE Pharma

1 Finar

6 Gangwal Chemicals

1 Ideal Cures Pvt Ltd

4 Kerry

1 Kima Chemical

6 Microlex e.U

1 Nanjing Bold Chemical

1 Pharmatrans-Sanaq

1 Pluviaendo

1 Prachin Chemical

8 Roquette

6 Seppic

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

8 Sigachi Industries

1 The Dow Chemical Company

1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

18 Fillers, Diluents & Binders

16 Thickeners and Stabilizers

15 Solubilizers

14 Direct Compression

10 Co-Processed Excipients

7 Parenteral

6 Controlled & Modified Release

6 Disintegrants & Superdisintegrants

5 Rheology Modifiers

5 Granulation

4 Coating Systems & Additives

4 Film Formers & Plasticizers

3 Emulsifying Agents

3 Taste Masking

3 Topical

2 Chewable & Orodispersible Aids

2 Lubricants & Glidants

2 Surfactant & Foaming Agents

1 API Stability Enhancers

DIGITAL CONTENT

AEROSOL, METERED;INHALATION - 0.04MG/INH Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

AEROSOL, METERED;INHALATION - 0.08MG/INH Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons